News Conference News TVT 2017 Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows Michael O'Riordan June 15, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017